AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations.
about
Microwave thermotherapy for benign prostatic hyperplasiaThe dark side of 5α-reductase inhibitors' therapy: sexual dysfunction, high Gleason grade prostate cancer and depressionOrgasm is preserved regardless of ejaculatory dysfunction with selective alpha1A-blocker administrationCurrent medical therapies for men with lower urinary tract symptoms and benign prostatic hyperplasia: achievements and limitationsThe role of lasers in modern urologyHolmium laser enucleation of the prostate: a review of the clinical trial evidenceEpidemiology of delayed ejaculationDrug-related problems in patients with benign prostatic hyperplasia: a cross sectional retrospective studyEffect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial.Performance of the American Urological Association Symptom Index with and without an additional urge incontinence item.Redesigning a large-scale clinical trial in response to negative external trial results: the CAMUS study of phytotherapy for benign prostatic hyperplasia.Predictor of de novo urinary incontinence following holmium laser enucleation of the prostate.Intraprostatic injection of botulinum toxin type-A relieves bladder outlet obstruction in human and induces prostate apoptosis in dogs.Simultaneous transurethral cystolithotripsy with holmium laser enucleation of the prostate: a prospective feasibility study and review of literature.Dropout in a longitudinal, cohort study of urologic disease in community men.Outcomes of 80 W KTP laser vaporization of the large prostate.Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia.Photoselective vaporization of the prostate: outcome according to the prostate size in a series of 102 Japanese patients.Drug treatment of urological symptoms: estimating the magnitude of unmet need in a community-based sampleCurrent status of 5alpha-reductase inhibitors in the management of lower urinary tract symptoms and BPH.Non-invasive parameters predicting bladder outlet obstruction in Korean men with lower urinary tract symptoms.Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome.Prostatic artery embolization as a primary treatment for benign prostatic hyperplasia: preliminary results in two patients.Evolution and success of holmium laser enucleation of the prostate.Long-term treatment with finasteride improves clinical progression of benign prostatic hyperplasia in men with an enlarged versus a smaller prostate: data from the MTOPS trialHolmium laser enucleation of prostate for benign prostatic hyperplasia: seoul national university hospital experienceClinical pearls in men's health.Progression of lower urinary tract symptoms in older men: a community based study.The benign prostatic hyperplasia registry and patient survey: study design, methods and patient baseline characteristics.MR imaging-guided cryoablation for the treatment of benign prostatic hyperplasia.Surgical intervention for symptomatic benign prostatic hyperplasia is correlated with expression of the AP-1 transcription factor networkChanges in initial expenditures for benign prostatic hyperplasia evaluation in the Medicare population: a comparison to overall Medicare inflationEffectiveness of medical and surgical therapies for lower urinary tract symptoms in the community settingTransitional zone index and intravesical prostatic protrusion in benign prostatic hyperplasia patients: correlations according to treatment received and other clinical data.National trends in surgical therapy for benign prostatic hyperplasia in the United States (2000-2008).Clinical outcome in male patients with detrusor overactivity with impaired contractilityEnucleation ratio efficacy might be a better predictor to assess learning curve of holmium laser enucleation of the prostate.Photoselective green-light laser vaporisation vs. TURP for BPH: meta-analysisThe application of 120-W high-performance system GreenLight laser vaporization of the prostate in high-risk patients.Investigation of ejaculatory disorder by silodosin in the treatment of prostatic hyperplasia
P2860
Q24243262-8014077D-D6C0-4AEE-93BA-8DA90D723F23Q24564068-8B3DBF9B-3282-4D1B-AC9E-2328649E2BEFQ24632336-2FFEF863-446F-444B-B41B-8047BBBF5DB4Q24649617-D8166C5B-AFF3-47BB-87AA-C71C5B9837B2Q26801224-7867F0EB-2534-45CA-8EF6-DA96C8BD6347Q27025826-E0C421E6-EAC1-4FED-AE0D-21C9D0F85979Q28066358-BE1B0233-3119-4C39-B4A0-33D9AB204AEBQ28539178-A57F7C11-A8A3-4914-B1D0-10E89926E1C4Q30424857-BEB488CD-6F5A-4432-868A-EEA8AD89617CQ30425356-BE302006-E1BF-44AB-8FD0-8BC99C6E3D20Q30432603-916A44A6-6B2D-4184-B8FE-EC12282F7B48Q31008587-B7FBCAA2-65A9-456B-8BA8-6736DE88EBD7Q33240172-5390CA16-F706-439E-B12B-0464C894C40EQ33259638-3C08206B-DEAA-422A-99F1-BB5C90019246Q33266615-16B59EED-B9EA-4C77-8D74-2DBF4177ACC5Q33306359-81C4BFA1-3F9A-41AB-9EF1-C65718698301Q33342249-09F64534-CDCD-4D8A-9AFE-FC47E9A5A16FQ33389352-B7A3985B-775F-44EB-8C59-59C70ACC3745Q33578216-92C7ACFC-EF7E-4CF0-B85E-A3B77D06355CQ33602452-B916E44F-4CFB-4A6E-BDCF-6AD1EEA8EA30Q33610021-0C859592-ADC4-44EB-A3AA-8ACAFBEBEC33Q33626306-7CB3DD89-DC72-43C1-A017-71D576ABE638Q33737556-1D270866-2429-44D3-8594-24902ED717A3Q33758265-D36F7FB2-625B-4D31-A2FE-1F22F191F489Q33824628-CD38DA1A-4CAC-414E-AB99-8175E8CCA0FBQ33863543-723AEAFD-8F7E-4DB8-898F-9CEC99D3CDCCQ33951568-03F17BF2-ACDB-43C4-ABCE-759A62E488B1Q33958191-0239A361-469E-4D29-A493-26CD1657AACFQ34006676-F4BF0C4C-6988-461B-8C3F-BEB2E91B2F2BQ34036244-49536102-CADB-44B2-BBB5-CAD6248753E7Q34163024-1643BBC6-1508-4931-ADC4-9FA8FCF8E04CQ34198543-3F9FA1B1-AE45-4856-827E-70E8BC60FEBAQ34218260-E9E8C648-760D-4428-A42E-FD6059BE0367Q34247583-AD278789-743B-4FF6-ABAA-C4F7E0751627Q34251961-8CF76B00-76D7-4200-AD97-7CF4F0648099Q34267500-72B913B2-7943-41D4-A58E-971B0FD132FAQ34327458-744DFDCA-27CD-4CBA-A000-AF1935940F6DQ34383667-837ABB05-7F6A-4E0D-8A39-4D5E96DA0A87Q34439936-39555266-450D-4A8A-80EC-839F6A8C486BQ34452517-53F03560-5EC3-477A-B848-72755B8DE271
P2860
AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
AUA guideline on management of ...... and treatment recommendations.
@ast
AUA guideline on management of ...... and treatment recommendations.
@en
type
label
AUA guideline on management of ...... and treatment recommendations.
@ast
AUA guideline on management of ...... and treatment recommendations.
@en
prefLabel
AUA guideline on management of ...... and treatment recommendations.
@ast
AUA guideline on management of ...... and treatment recommendations.
@en
P1476
AUA guideline on management of ...... and treatment recommendations.
@en
P2093
AUA Practice Guidelines Committee
P304
P356
10.1097/01.JU.0000078083.38675.79
P407
P433
P577
2003-08-01T00:00:00Z